Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Having -c- – wherein x is chalcogen – bonded directly to...
Patent
1984-04-12
1985-05-21
Siegel, Alan
Drug, bio-affecting and body treating compositions
Designated organic active ingredient containing
Having -c-, wherein x is chalcogen, bonded directly to...
514443, 549 57, 549 71, 549 72, 549467, 549468, 549484, 549487, 514461, 514469, 514471, A61K 3138, A61K 3134
Patent
active
045186090
ABSTRACT:
Naphthenic and heterocyclic retinoic acid analogues such as (E)-6-[2-(2,6,6-trimethyl-1-cyclohexen-1-yl)ethenyl]-2-naphthaldehyde, methyl 6-[2-(2,6,6-trimethyl-1-cyclohexen-1-yl)ethenyl]-2-naphthoate, 6-[2-(2,6,6-trimethyl-1-cyclohexen-1-yl)ethenyl]-2-naphthoic acid, (E)-1-(5-carbethoxy-2-furanyl)-2-methyl-4-(2,6,6-trimethyl-1-cyclohexen-1- yl)-1,3-butadiene, (E)-1-(5-carboxy-2-furanyl)-2-methyl-4-(2,6,6-trimethyl-1-cyclohexen-1-yl) -1,3-butadiene, (E)-1-(5-carbethoxythien-2-yl)-2-methyl-4-(2,6,6-trimethyl-1-cyclohexen-1- yl)-1,3-butadiene, and (E)-1-(5-carboxythien-2-yl)-2-methyl-4-(2,6,6-trimethyl-1-cyclohexen-1-yl) -1,3-butadiene. These retinoids are useful as chemopreventive agents for inhibiting tumor promotion in epithelial cells and for treating nonmalignant skin disorders.
REFERENCES:
patent: 4456618 (1984-06-01), Dawson et al.
Boutwell et al., Advances in Enzyme Regulation, vol. 17, (1979), pp. 89-112.
Verma et al., Cancer Res., vol. 39, (1979), pp. 419-427.
Dawson et al., J. Med. Chem., vol. 23, (1980), pp. 1013-1022.
Dawson et al., J. Med. Chem., vol. 24, (1981), pp. 583-592.
Chan Rebecca L. S.
Dawson Marcia I.
Siegel Alan
SRI - International
LandOfFree
Naphtenic and heterocyclic retinoic acid analogues does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Naphtenic and heterocyclic retinoic acid analogues, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Naphtenic and heterocyclic retinoic acid analogues will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-1537894